Company Filing History:
Years Active: 2015-2019
Title: Gang Shen: Innovator in Genetic Therapies
Introduction
Gang Shen is a notable inventor based in Andover, MA (US), recognized for his contributions to the field of genetic therapies. He holds three patents that focus on innovative treatments for diseases related to alpha-L-iduronidase (IDUA). His work has significant implications for the medical community and patients suffering from related disorders.
Latest Patents
One of Gang Shen's latest patents involves the treatment of alpha-L-iduronidase (IDUA) related diseases by inhibiting the natural antisense transcript to IDUA. This invention relates to antisense oligonucleotides that modulate the expression and function of Alpha-L-Iduronidase (IDUA). Specifically, it targets natural antisense polynucleotides of IDUA. The invention also encompasses the identification of these antisense oligonucleotides and their application in treating diseases and disorders associated with IDUA expression.
Career Highlights
Gang Shen is currently associated with Curna, Inc., where he continues to advance his research and innovations. His work is pivotal in developing therapies that can potentially change the lives of many patients.
Collaborations
Some of his notable coworkers include Joseph Collard and Olga Khorkova Sherman, who contribute to the collaborative efforts in their research endeavors.
Conclusion
Gang Shen's innovative work in the field of genetic therapies highlights his commitment to addressing critical health challenges. His patents represent significant advancements in the treatment of IDUA-related diseases, showcasing the impact of his research on future medical therapies.